Brain monitor may predict ICU patient survival
NCT ID NCT07583732
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will use a simple brain wave monitor (BIS) to track brain activity in 40 critically ill ICU patients—some with decreased consciousness and some without. The goal is to see if BIS readings can predict how long patients stay in the ICU, whether they survive, and their recovery at 30 and 90 days. The research is purely observational and does not test any new drug or treatment.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Processed EEG monitoring (BIS monitor)
- What this could lead to
- If successful, this could help doctors better predict recovery and guide care for ICU patients with reduced consciousness.
- What could go wrong
- This is a small, early-stage observational study with only 40 participants. It is not testing a treatment, so it cannot directly improve patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Age≥18years 2. RASS score ≤ -3 as case 3. RASS score 0 to -1 as control 4. Expected ICU length of stays ≥ 24hours Exclusion Criteria: 1. Contraindication for BIS monitoring (wound or infection at forehead) 2. No space for attach BIS monitoring at forehead 3. Patient with sedative drugs (Propofol, Midazolam, Dexmedetomidine) 4. Patient with acute stroke 5. Patient was already on EEG monitoring 6. Denied by patients or patient's surrogates
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Critically ill patients are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University
Bangkok Noi, Bangkok, 10700, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breath analysis may offer a Needle-Free way to track critical Acid-Base balance
- A gentle touch from family may calm the ICU storm
- Could a Ketamine-Like drug make emergency ICU intubations safer?
- ICU superbug study aims to protect vulnerable patients
- AI could help nurses measure heart function as well as experts
- Ancient syrup could be key to ICU recovery